A. Mazumder

发表

Technology for microarray analysis of gene expression.

A. Watson, A. Mazumder, M. Stewart, 1998, Current opinion in biotechnology.

An assessment of Motorola CodeLink microarray performance for gene expression profiling applications.

R. Shippy, D. Dorris, A. Mazumder, 2002, Nucleic acids research.

Oligodeoxyribonucleotide probe accessibility on a three-dimensional DNA microarray surface and the effect of hybridization time on the accuracy of expression ratios

D. Dorris, A. Mazumder, R. Elghanian, 2003, BMC biotechnology.

Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions

Yixin Wang, D. Talantov, Jack X. Yu, 2005, Clinical Cancer Research.

Quantitative, spatial resolution of the epigenetic field effect in prostate cancer

A. Mazumder, R. Nagle, S. Varde, 2008, The Prostate.

Prognostic gene expression signatures can be measured in tissues collected in RNAlater preservative.

Yi Zhang, Yixin Wang, A. Mazumder, 2006, The Journal of molecular diagnostics : JMD.

Quantitative assessment of the use of modified nucleoside triphosphates in expression profiling: differential effects on signal intensities and impacts on expression ratios

D. Dorris, A. Mazumder, Connie Zhao, 2002, BMC biotechnology.

Expressions of CK-19, NF-kappaB, E-cadherin, beta-catenin and EGFR as diagnostic and prognostic markers by immunohistochemical analysis in thyroid carcinoma.

A. Mazumder, M. Mandal, S. Rajput, 2011, Journal of experimental therapeutics & oncology.

Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer.

Marek Skacel, Graham Casey, Yi Zhang, 2008, The Journal of molecular diagnostics : JMD.

A highly reproducible, linear, and automated sample preparation method for DNA microarrays.

Ramesh Ramakrishnan, Richard Belval, Allen Nguyen, 2002, Genome research.

Quantifying factors for the success of stratified medicine

Jian Wang, Mark R. Trusheim, Ernst R. Berndt, 2011, Nature Reviews Drug Discovery.

Suspension arrays for high throughput, multiplexed single nucleotide polymorphism genotyping.

A. Mazumder, M. Stewart, B. Armstrong, 2000, Cytometry.

Molecular and cellular approaches to patient management in oncology.

Yixin Wang, A. Mazumder, J. Godsey, 2006, Personalized medicine.

A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin.

David C. Atkins, T. Jatkoe, A. Mazumder, 2006, The Journal of molecular diagnostics : JMD.

A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin.

Yixin Wang, T. Jatkoe, D. Atkins, 2006, The Journal of molecular diagnostics : JMD.

Novel Genes AssociatedwithMalignantMelanoma but not BenignMelanocytic Lesions

Yixin Wang, D. Talantov, D. Atkins, 2005 .

Expression Profiling with Oligonucleotide Arrays: Technologies and Applications for Neurobiology

Ramesh Ramakrishnan, Allen Nguyen, D. Dorris, 2002, Neurochemical Research.

Gene-expression signatures in oncology diagnostics.

Yixin Wang, A. Mazumder, 2006, Pharmacogenomics.

Validation and integration of gene-expression signatures in cancer

Yixin Wang, A. Mazumder, A. Palma, 2008, Expert review of molecular diagnostics.

Development of a multiplexed urine assay for prostate cancer diagnosis.

A. Mazumder, B. Leibovich, D. Chowdary, 2008, Clinical chemistry.

Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative Colitis.

T. Davison, A. Mazumder, P. Rutgeerts, 2018, Gastroenterology.

Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer.

Elena A. Manilich, Yixin Wang, Yi Zhang, 2008, The Journal of molecular diagnostics : JMD.

Oligonucleotide Array Technologies for Gene Expression Profiling

R. Shippy, D. Dorris, A. Mazumder, 2003 .